TSE:BHC Bausch Health Companies Q3 2025 Earnings Report C$8.74 -0.29 (-3.21%) As of 04:19 PM Eastern ProfileEarnings HistoryForecast Bausch Health Companies EPS ResultsActual EPSC$0.48Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ABausch Health Companies Revenue ResultsActual Revenue$2.68 billionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABausch Health Companies Announcement DetailsQuarterQ3 2025Date10/29/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Bausch Health Companies Earnings HeadlinesZacks Research Has Bearish Outlook for TSE:BHC Q3 EarningsAugust 23, 2026 | americanbankingnews.comBrokers Set Expectations for TSE:BHC FY2026 EarningsAugust 22, 2026 | americanbankingnews.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.August 27 at 1:00 AM | Porter & Company (Ad)Why Bausch Health (BHC) is a top momentum stock for the long termAugust 11, 2026 | msn.comBausch Health (BHC) Q2 2026 Earnings Call TranscriptAugust 7, 2026 | finance.yahoo.comBausch Health Chief Executive Thomas Appio Appointed to Bausch + Lomb BoardAugust 7, 2026 | finance.yahoo.comSee More Bausch Health Companies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bausch Health Companies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bausch Health Companies and other key companies, straight to your email. Email Address About Bausch Health CompaniesBausch Health Companies (TSE:BHC) (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.View Bausch Health Companies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes ShapeNVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout IsMarvell’s Big AI Test Comes One Day After NVIDIA’s Blowout QuarterWhen Unusual Volume Isn't Noise: 3 Small-Caps Sending SignalsSemtech Stock Rallies on Strong Q2 Results and Raised GuidanceWilliams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-RaiseSEC Probe Puts Wall Street Leverage Risk Back in Focus Upcoming Earnings Medtronic (9/1/2026)Dell Technologies (9/1/2026)Palo Alto Networks (9/1/2026)Broadcom (9/2/2026)Hewlett Packard Enterprise (9/2/2026)Snowflake (9/2/2026)Ciena (9/3/2026)Oracle (9/8/2026)Adobe (9/10/2026)FedEx (9/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
